Impact and Safety of Chimeric Antigen Receptor T Cell Therapy in Older, Vulnerable Patients With Relapsed/Refractory Large B-Cell Lymphoma
Haematologica - Italy
doi 10.3324/haematol.2019.243246
Full Text
Open PDFAbstract
Available in full text
Categories
Date
February 20, 2020
Authors
Publisher
Ferrata Storti Foundation (Haematologica)